European Archives - Page 773 of 1506 - European Medical Journal

The Spectrum of Viruses Causing Hepatitis

VIRAL hepatitis presents one of the most diverse challenges currently perplexing experts within the field of hepatology…

EASL 2023 Interview: Marina Berenguer

I started doing gastroenterology because of my father, who was a gastroenterologist, and who started the Liver Transplant Unit in Valencia…

EAN 2023 Interview: László Oláh

I have always been attracted to mathematics and logic, and during my university studies I found neurology to be the most logical subject…

Link Between Rheumatoid Arthritis and Parkinson’s Disease Found

Patients with rheumatoid arthritis have a 1.74-fold increased risk for developing Parkinson’s disease. Read more…

Ovarian Hyperstimulation Syndrome Post-dilation and Evacuation of a Hydatidiform Mole: A Case Report

The present study reports a complete hydatidiform mole presenting with ovarian hyperstimulation syndrome after dilatation and evacuation…

EMJ Hematology 11 [Supplement 4] 2023

The thalassaemias are a heterogenous group of inherited blood disorders with the commonality of impaired haemoglobin synthesis, resulting…

Expert Insights: Phase III Clinical Trials in Non-Transfusion-Dependent (ENERGIZE) and Transfusion-Dependent (ENERGIZE-T) α- and β-Thalassaemia

The thalassaemias are a heterogeneous group of inherited chronic blood disorders associated with impaired haemoglobin (Hb) synthesis…

Staying out of hot water on social media

As the UK PMCPA publishes its first social media guidance for pharmaceutical companies, what can they do to avoid traps when it comes to posting online?

EMJ Hematology 11 [Supplement 3] 2023

This article highlights key insights from a symposium on treatment options for patients with relapsed/refractory diffuse large B cell…

What to Do When Chimeric Antigen Receptor T Cells Are Not the Most Appropriate Option in Second-Line Diffuse Large B Cell Lymphoma: Current Treatment Options for Transplant-Ineligible Patients

DLBCL accounts for approximately 30% of non-Hodgkin’s lymphomas diagnosed each year. Initially, DLBCL is generally treated…